Go Pro

ICU Medical (ICUI) Competitors

ICU Medical logo
$175.10 0.00 (0.00%)
As of 08/28/2026 04:00 PM Eastern

ICUI vs. SOLV, COO, ALGN, BLCO, and MMSI

Should you buy ICU Medical stock or one of its competitors? ICU Medical's main competitors and comparable companies include Solventum (SOLV), Cooper Companies (COO), Align Technology (ALGN), Bausch + Lomb (BLCO), and Merit Medical Systems (MMSI). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does ICU Medical compare to Solventum?

ICU Medical (NASDAQ:ICUI) and Solventum (NYSE:SOLV) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, dividends, valuation and profitability.

In the previous week, ICU Medical had 5 more articles in the media than Solventum. MarketBeat recorded 9 mentions for ICU Medical and 4 mentions for Solventum. ICU Medical's average media sentiment score of 1.37 beat Solventum's score of 1.13 indicating that ICU Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
ICU Medical
6 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Solventum
3 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Solventum has a net margin of 17.26% compared to ICU Medical's net margin of 1.39%. Solventum's return on equity of 25.09% beat ICU Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
ICU Medical1.39% 7.91% 4.17%
Solventum 17.26%25.09%8.78%

Solventum has higher revenue and earnings than ICU Medical. Solventum is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ICU Medical$2.23B1.96$730K$1.18148.39
Solventum$8.31B1.86$1.56B$8.1811.13

ICU Medical currently has a consensus target price of $192.80, suggesting a potential upside of 10.11%. Solventum has a consensus target price of $91.64, suggesting a potential upside of 0.68%. Given ICU Medical's stronger consensus rating and higher possible upside, research analysts plainly believe ICU Medical is more favorable than Solventum.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ICU Medical
0 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
2 Strong Buy rating(s)
2.89
Solventum
1 Sell rating(s)
4 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.54

96.1% of ICU Medical shares are held by institutional investors. 2.1% of ICU Medical shares are held by insiders. Comparatively, 0.2% of Solventum shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

ICU Medical has a beta of 0.74, meaning that its share price is 26% less volatile than the broader market. Comparatively, Solventum has a beta of 0.6, meaning that its share price is 40% less volatile than the broader market.

Summary

ICU Medical beats Solventum on 10 of the 17 factors compared between the two stocks.

How does ICU Medical compare to Cooper Companies?

Cooper Companies (NASDAQ:COO) and ICU Medical (NASDAQ:ICUI) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, valuation, institutional ownership, risk, dividends, earnings and analyst recommendations.

Cooper Companies has a net margin of 5.57% compared to ICU Medical's net margin of 1.39%. Cooper Companies' return on equity of 10.88% beat ICU Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Cooper Companies5.57% 10.88% 7.27%
ICU Medical 1.39%7.91%4.17%

Cooper Companies currently has a consensus price target of $81.64, indicating a potential upside of 14.72%. ICU Medical has a consensus price target of $192.80, indicating a potential upside of 10.11%. Given Cooper Companies' higher possible upside, equities analysts plainly believe Cooper Companies is more favorable than ICU Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cooper Companies
3 Sell rating(s)
6 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.35
ICU Medical
0 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
2 Strong Buy rating(s)
2.89

Cooper Companies has higher revenue and earnings than ICU Medical. Cooper Companies is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cooper Companies$4.09B3.39$374.90M$1.1860.31
ICU Medical$2.23B1.96$730K$1.18148.39

24.4% of Cooper Companies shares are held by institutional investors. Comparatively, 96.1% of ICU Medical shares are held by institutional investors. 2.1% of Cooper Companies shares are held by company insiders. Comparatively, 2.1% of ICU Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Cooper Companies has a beta of 0.83, meaning that its share price is 17% less volatile than the broader market. Comparatively, ICU Medical has a beta of 0.74, meaning that its share price is 26% less volatile than the broader market.

In the previous week, Cooper Companies had 22 more articles in the media than ICU Medical. MarketBeat recorded 31 mentions for Cooper Companies and 9 mentions for ICU Medical. ICU Medical's average media sentiment score of 1.37 beat Cooper Companies' score of 1.04 indicating that ICU Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cooper Companies
23 Very Positive mention(s)
3 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Positive
ICU Medical
6 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Cooper Companies beats ICU Medical on 10 of the 16 factors compared between the two stocks.

How does ICU Medical compare to Align Technology?

ICU Medical (NASDAQ:ICUI) and Align Technology (NASDAQ:ALGN) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, dividends, institutional ownership, analyst recommendations, earnings and valuation.

Align Technology has higher revenue and earnings than ICU Medical. Align Technology is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ICU Medical$2.23B1.96$730K$1.18148.39
Align Technology$4.03B2.80$410.35M$5.7527.41

Align Technology has a net margin of 9.99% compared to ICU Medical's net margin of 1.39%. Align Technology's return on equity of 15.86% beat ICU Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
ICU Medical1.39% 7.91% 4.17%
Align Technology 9.99%15.86%10.32%

ICU Medical presently has a consensus price target of $192.80, indicating a potential upside of 10.11%. Align Technology has a consensus price target of $206.36, indicating a potential upside of 30.95%. Given Align Technology's higher possible upside, analysts clearly believe Align Technology is more favorable than ICU Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ICU Medical
0 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
2 Strong Buy rating(s)
2.89
Align Technology
0 Sell rating(s)
6 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.67

96.1% of ICU Medical shares are held by institutional investors. Comparatively, 88.4% of Align Technology shares are held by institutional investors. 2.1% of ICU Medical shares are held by insiders. Comparatively, 0.8% of Align Technology shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

ICU Medical has a beta of 0.74, indicating that its stock price is 26% less volatile than the broader market. Comparatively, Align Technology has a beta of 1.65, indicating that its stock price is 65% more volatile than the broader market.

In the previous week, Align Technology had 6 more articles in the media than ICU Medical. MarketBeat recorded 15 mentions for Align Technology and 9 mentions for ICU Medical. ICU Medical's average media sentiment score of 1.37 beat Align Technology's score of 1.30 indicating that ICU Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
ICU Medical
6 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Align Technology
12 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Align Technology beats ICU Medical on 11 of the 17 factors compared between the two stocks.

How does ICU Medical compare to Bausch + Lomb?

ICU Medical (NASDAQ:ICUI) and Bausch + Lomb (NYSE:BLCO) are both mid-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their earnings, valuation, risk, institutional ownership, dividends, profitability, media sentiment and analyst recommendations.

ICU Medical has a net margin of 1.39% compared to Bausch + Lomb's net margin of -3.21%. ICU Medical's return on equity of 7.91% beat Bausch + Lomb's return on equity.

Company Net Margins Return on Equity Return on Assets
ICU Medical1.39% 7.91% 4.17%
Bausch + Lomb -3.21%4.14%1.93%

ICU Medical presently has a consensus price target of $192.80, suggesting a potential upside of 10.11%. Bausch + Lomb has a consensus price target of $18.75, suggesting a potential upside of 9.46%. Given ICU Medical's stronger consensus rating and higher possible upside, analysts plainly believe ICU Medical is more favorable than Bausch + Lomb.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ICU Medical
0 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
2 Strong Buy rating(s)
2.89
Bausch + Lomb
1 Sell rating(s)
7 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.31

In the previous week, Bausch + Lomb had 4 more articles in the media than ICU Medical. MarketBeat recorded 13 mentions for Bausch + Lomb and 9 mentions for ICU Medical. ICU Medical's average media sentiment score of 1.37 beat Bausch + Lomb's score of 0.31 indicating that ICU Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
ICU Medical
6 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Bausch + Lomb
4 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
2 Very Negative mention(s)
Neutral

ICU Medical has higher earnings, but lower revenue than Bausch + Lomb. Bausch + Lomb is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ICU Medical$2.23B1.96$730K$1.18148.39
Bausch + Lomb$5.10B1.20-$360M-$0.48N/A

ICU Medical has a beta of 0.74, suggesting that its share price is 26% less volatile than the broader market. Comparatively, Bausch + Lomb has a beta of 0.56, suggesting that its share price is 44% less volatile than the broader market.

96.1% of ICU Medical shares are owned by institutional investors. Comparatively, 11.1% of Bausch + Lomb shares are owned by institutional investors. 2.1% of ICU Medical shares are owned by company insiders. Comparatively, 1.5% of Bausch + Lomb shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

ICU Medical beats Bausch + Lomb on 14 of the 17 factors compared between the two stocks.

How does ICU Medical compare to Merit Medical Systems?

Merit Medical Systems (NASDAQ:MMSI) and ICU Medical (NASDAQ:ICUI) are both mid-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations, profitability and earnings.

99.7% of Merit Medical Systems shares are held by institutional investors. Comparatively, 96.1% of ICU Medical shares are held by institutional investors. 0.7% of Merit Medical Systems shares are held by company insiders. Comparatively, 2.1% of ICU Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Merit Medical Systems has higher earnings, but lower revenue than ICU Medical. Merit Medical Systems is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Merit Medical Systems$1.52B3.56$128.49M$2.4237.39
ICU Medical$2.23B1.96$730K$1.18148.39

Merit Medical Systems currently has a consensus target price of $100.00, suggesting a potential upside of 10.51%. ICU Medical has a consensus target price of $192.80, suggesting a potential upside of 10.11%. Given Merit Medical Systems' higher possible upside, analysts plainly believe Merit Medical Systems is more favorable than ICU Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Merit Medical Systems
0 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.83
ICU Medical
0 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
2 Strong Buy rating(s)
2.89

Merit Medical Systems has a net margin of 9.22% compared to ICU Medical's net margin of 1.39%. Merit Medical Systems' return on equity of 13.75% beat ICU Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Merit Medical Systems9.22% 13.75% 8.10%
ICU Medical 1.39%7.91%4.17%

Merit Medical Systems has a beta of 0.49, meaning that its stock price is 51% less volatile than the broader market. Comparatively, ICU Medical has a beta of 0.74, meaning that its stock price is 26% less volatile than the broader market.

In the previous week, Merit Medical Systems had 15 more articles in the media than ICU Medical. MarketBeat recorded 24 mentions for Merit Medical Systems and 9 mentions for ICU Medical. ICU Medical's average media sentiment score of 1.37 beat Merit Medical Systems' score of 1.26 indicating that ICU Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Merit Medical Systems
11 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
ICU Medical
6 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Merit Medical Systems beats ICU Medical on 10 of the 17 factors compared between the two stocks.

Get ICU Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for ICUI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ICUI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ICUI vs. The Competition

MetricICU MedicalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$4.38B$5.84B$7.20B$12.90B
Dividend YieldN/A1.75%2.54%11.28%
P/E Ratio148.3925.92273.1625.45
Price / Sales1.9667.90592.6473.57
Price / Cash12.0133.0376.7453.00
Price / Book2.036.1812.986.14
Net Income$730K$149.01M$3.48B$348.86M
7 Day Performance-4.23%-0.24%0.13%-0.80%
1 Month Performance3.99%6.18%7.08%4.13%
1 Year Performance37.16%6.30%24.67%15.17%

ICU Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ICUI
ICU Medical
3.4827 of 5 stars
$175.10
flat
$192.80
+10.1%
+37.2%$4.38B$2.23B148.3913,000
SOLV
Solventum
2.3024 of 5 stars
$90.58
-0.7%
$91.64
+1.2%
+24.4%$15.43B$8.33B11.0820,000
COO
Cooper Companies
3.652 of 5 stars
$74.53
-1.7%
$81.64
+9.5%
+5.6%$14.53B$4.09B63.1515,000
ALGN
Align Technology
4.5866 of 5 stars
$158.77
-0.5%
$206.36
+30.0%
+11.0%$11.36B$4.03B27.5820,290
BLCO
Bausch + Lomb
3.1559 of 5 stars
$17.36
+0.3%
$18.75
+8.0%
+17.1%$6.19B$5.10BN/A13,000

Related Companies and Tools


This page (NASDAQ:ICUI) was last updated on 8/30/2026 by MarketBeat.com Staff.
From Our Partners